PE(16:0/22:5(4Z,7Z,10Z,13Z,16Z))

Metabolite details

Identifier

VFGMWCSZLGEBAJ-OYUCTCCDSA-N

InChI Key

VFGMWCSZLGEBAJ-OYUCTCCDSA-N

IUPAC name

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate

Preferred name

PE(16:0/22:5(4Z,7Z,10Z,13Z,16Z))

INN name

—

Synonym

—

ChEBI

CHEBI:170587

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma

Observed in differential profiles

• Wild_type_vs_hfq
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Normal_control_no_tumor_vs_FH_deficient_RCC